Background. Of the respiratory syncytial virus (RSV) genotypes previously described in South Africa during 1997 , only GA2 and GA5 persisted until 2006, with BA having replaced all previous RSV-B genotypes. This poses the question whether RSV-A is more stable than RSV-B and whether positive selection drives evolution of genotypes.
Although respiratory syncytial virus (RSV) infection affects all age groups, it can be particularly severe in infants, immunocompromised patients, and elderly individuals [1] . RSV causes infection and re-infection during infancy and throughout life, despite the presence of maternal antibodies in young infants and prior infections in adults, without the need for significant antigenic changes [2] . Antigenic variation may, however, contribute to the susceptibility of some individuals to repeated infection [3] .
The 2 major RSV subgroups are A (RSV-A) and B (RSV-B), and they are further characterized into several genotypes, based on antigenic and genetic variability of the second hypervariable region of the G-protein, which provides a reliable proxy for the entire G-protein variation [4, 5] . Several genotypes can co-circulate in a single epidemic season, and different genotypes can dominate in consecutive seasons [6] [7] [8] [9] [10] . To date, eleven genotypes for RSV-A have been identified and include GA1-7 [4, 5] , SAA1 [7] , NA1, NA2, and ON1, which has a 72-bp duplication insertion [11] . For RSV-B, the genotypes are GB1-4 [4, 5] , SAB1-3 [7, 12] , and the BA genotype, which has a 60-bp insertion [13] and has subsequently been classified into subgenotypes BA1-10 [14, 15] .
In previous studies conducted in South Africa during 1997-2001, we reported the circulation of GA2, GA5, GA7, GB3, and GA4, as well as novel genotypes such as SAA1, SAB1, SAB2, and SAB3 [7, 12, 16] . These novel genotypes have subsequently been identified worldwide [10, 17] . The BA genotype was first detected in South Africa during the investigation of a nosocomial outbreak, in 2006 [18] , and we subsequently showed that BA had replaced all previously described RSV-B genotypes in South Africa [6] . Also, until 2009, GA2 and GA5 were the only subtype A genotypes still circulating in South Africa, suggesting that these RSV-A genotypes have been stable over the past 9 years. However, poor bootstrap and pairwise distance analysis suggested that drift may be occurring. The objective of this study was to compare the genotypic characteristics of RSV identified through a surveillance program in South Africa, conducted during 2009-2012 to investigate the prevalence of respiratory viruses among individuals hospitalized for severe acute respiratory infections (SARIs), and to compare these to the genotypes of RSV identified in South Africa during 1997-2001 and 2006-2009 , as well as to RSV identified elsewhere globally.
MATERIALS AND METHODS

Study Design and Sample Collection
SARI Surveillance Program (2009-2012)
Specimens were collected as part of a prospective hospitalbased sentinel surveillance program conducted from February 2009 through May 2012, which aimed to determine respiratory viruses and risk factors associated with hospitalization for SARI in South Africans of all age groups. The methods of this study have been previously described [19] . The participating SARI surveillance sites are Chris Hani Baragwanath Academic Hospital (CHBAH; Gauteng Province), Edendale Hospital (KwaZulu-Natal Province), Matikwana and Mapulaneng hospitals (Mpumalanga Province), and Tshepong and Klerksdorp hospitals (North-West Province). RSV-positive specimens from individuals of all age groups with a known human immunodeficiency virus infection status, and RSV from a percentage of positive specimens were selected at random retrospectively from the 4-year period for sequencing. The genotypic profile of RSV obtained from the SARI program during 2009-2012 was compared to that of RSV previously identified in South Africa.
RSV Previously Identified in South Africa
Samples were obtained from children aged <5 years from CHBAH (Soweto) during 1997-2000 [7] and from children <5 years from community clinics in Agincourt during 1998-2001 [12] . Additional samples were obtained from high-risk children from across the country during 2000-2001 [16] and primarily from hospitalized patients, mostly children, in Steve Biko and Kalafong academic hospitals (Pretoria, South Africa) during 2006-2009 [6] .
Detection of Respiratory Viruses
All SARI specimens were tested using a real-time reversetranscription polymerase chain reaction (rRT-PCR) protocol described by Pretorius et al [19] and were screened for parainfluenza types 1-3, RSV, influenza A and B viruses, adenovirus, enterovirus, human metapneumovirus, and rhinovirus.
Full RSV G-protein Gene Amplification
The complete or near-complete RSV G genes were amplified by nested PCR. Briefly, complementary DNA (cDNA) was synthesized with random primers using SuperScript reverse transcriptase (Invitrogen, Life Technologies, Carlsbad, CA, USA) according to manufacturer's instructions. Full-length RSV Gprotein genes were amplified using Platinum Pfx DNA polymerase (Invitrogen, Life Technologies) with primers G1-21 [20] and F164 [21] . In brief how to set up the full g-protein amplification. 5 µL of cDNA was added to 7.5 µL of 10× reaction buffer, 10 mM each deoxynucleoside triphosphate (dNTP), 10 pmol each primer (G1-21 and F164), 50 mM MgSO 4 1.25 U of Platinum Pfx DNA polymerase up to a 50-µL final volume. The following cycling conditions were used: 1 cycle at 94°C for 2 minutes; 40 cycles at 94°C for 15 seconds, 55°C for 30 seconds, 68°C for 2 minutes; and 1 cycle at 68°C for 10 minutes. This was followed by nested PCR with forward primers G32A(RSV-A), G32B(RSV-B), G598A(RSV-A), and G604B(RSV-B) [22] and reverse primers G665R [22] and F1 [5] . The nested PCR was conducted in a 50-µL reaction mixture volume. In brief, 1 µL of the first round product was added to 7.5 µL 10× reaction buffer, 10 mM each dNTP, 10 pmol each primer, 50 mM MgSO 4 1.25 U of Platinum Pfx DNA polymerase, using the same cycling conditions as the first round. PCR products were analyzed on a 1% agarose gel against a 100-bp ladder as a molecular weight marker (DNA molecular marker XIV; Roche Diagnostics, Mannheim, Germany).
Subtyping of RSV
Subtyping-specific primers were used to determine the subtype as either RSV-A or RSV-B, using the amplied full g-protein as described before on the full-length G-protein gene by nested PCR with forward primers G52B and G598A [22] and reverse primer F1 [5] , or directly by sequencing using a combination of the primers listed above (Supplementary Table 1 ).
Nucleotide Sequencing
PCR products were purified using the ExoSAP-IT enzyme system (USB, Cleveland, OH). Cycle sequencing was performed with a BigDye terminator 3.1 cycle sequencing kit as recommended by the manufacturer (Applied Biosystems, Foster City, CA). Nucleotide sequencing was performed on both strands, and the editing S228 • JID 2013:208 (Suppl 3) • Pretorius et al was performed with Sequencher, version 5 (Gene Codes, Ann Arbor, MI, USA).
Phylogenetic Analysis
A region spanning 270 nucleotides in RSV-A and 330 nucleotides in RSV-B, representing the second hypervariable region of the G-protein gene, was used for phylogenetic analysis [23] . The South African RSV sequences were compared against reference sequences of each genotype in the GenBank database (available at: http://www.ncbi.nlm.nih.gov/GenBank/index.html). All South African strains present in the database from our previous investigations in Pretoria (2006 Pretoria ( -2009 [6, 18] , Soweto (1997 Soweto ( -2001 [11] , and Agincourt, Pretoria, Bloemfontein, Cape Town, and Durban (2000) [7, 12, 22] were also included. Nucleotide sequences of RSV-A and RSV-B viruses were aligned separately with ClustalX 1.81 [24] embedded in BioEdit Sequence Alignment Editor, version 7.0.4.1 [25] . Because most previously published sequences were based only on the second variable region, phylogenetic analysis was based on this region for all strains.
Nucleotide and Amino Acid Sequence Analysis
The pairwise distance ( p-distance) was calculated between individual genotypes, as well as within each genotype, using Mega, version 5 [26] . Estimates of evolution were based on the ratio of the number of nonsynonymous substitutions per nonsynonymous site (Ka) to the number of synonymous substitutions per synonymous site (Ks). These estimates were calculated with the modified Nei-Gojobori method in Mega, version 5 [27] ; a ratio of Ka to Ks of > 1 indicates positive selection. Amino acid analysis for individual genotypes were calculated for the full G-protein ectodomain of representative strains of each genotype, using Genedoc, version 2.6.003 (available at: http://www.nrbsc.org/gfx/genedoc/).
Evolutionary Rate and Most Recent Common Ancestor (MRCA)
The evolutionary analyses over time were conducted using a coalescent Bayesian Markov chain Monte Carlo (MCMC) approach, as implemented in BEAST (Bayesian Evolutionary Analysis by Sampling Trees), version 1.4.6 [23] , to estimate the rate of evolution. MCMC chains were run for a sufficient time to achieve convergence (as assessed using Tracer). Dates were introduced according to the year of isolation. Maximum clade credibility trees were generated using Tree Annotator, and all trees were plotted using FigTree, version 1.1.2 (available at: http:// tree.bio.ed.ac.uk/). Using the root-to-tip regression analysis that displays the correlation between phylogenetic branch length and the time of sampling of the viral strains, which in turn calculates the most resent common ancestor (MRCA) for all of the sequences under analysis (Path-o-Gen version 1.3 available at: http:// tree.bio.ed.ac.uk/software/pathogen); plot as performed with Patho-Gen version 1.3 (available at: http://tree.bio.ed.ac.uk/software/ pathogen); this displays the correlation between phylogenetic branch length and the time of sampling of the viral strains to calculate the MRCA for all of the sequences under analysis.
Selective Pressure Analysis
Selective pressure analysis was conducted by use of the Datamonkey Web server (available at: http://www.datamonkey.org), which estimated the rates of nonsynonymous and synonymous changes at each site in a sequence alignment, to identify sites under positive or negative selection [28] [29] [30] .
Statistical Analysis
The frequency of RSV subtypes was calculated with the Fisher exact test, using Stata 10 (College Station, TX). P values of <05 were considered statistically significant.
Nucleotide Sequence Accession Numbers
Sequences of partial and full G-protein genes were submitted to GenBank (accession numbers KC476656-KC477097).
Ethical Considerations
The protocol was reviewed and approved by the University of the Witwatersrand Human Research Ethics Committee and the University of KwaZulu-Natal Human Biomedical Research Ethics Committee ( protocols M081042 and BF157/08, respectively).
RESULTS
Detection of Respiratory Viruses and Characteristics of RSVPositive Patients Identified in the SARI Surveillance Program During 2009-2012
During February 2009-May 2012, we enrolled 13 664 patients meeting the SARI case definition, of whom 13 432 (98%) were tested for respiratory viruses. RSV was detected in 2182 individuals (16%), including 1111 (51%) in whom RSV was the sole pathogen identified. The proportion testing positive for RSV varied by age group: 31% (1387/4542) among individuals aged 0-2 years, 20% (536/2631) among those aged 2-4 years, 7% (35/479) among those aged 5-14 years, 3% (17/525) among those aged 15-24 years, 4% (140/3295) among those aged 25-44 years, 4% (59/1568) among those aged 45-64 years, and 2% (7/373) among those aged >65 years (P < .001).
Evolution of RSV Subtypes
Among the 486 randomly selected RSV-positive specimens recovered from the SARI program between 2009 and 2012 that were further investigated, RSV-A was detected in 282 (58%), and RSV-B was detected in 204 (42%; P = .001). RSV-A predominated in 2 of the 4 seasons ( Table 1) Figure 2A ). Although strong bootstrap values could be obtained for all strains clustering with GA5, 3 GA5 subclusters were identified since its emergence 19 years ago and were named GA5I-III (Figures 2A and 3A) . All of the Pairwise Distances SAA2 strains were distinct from strains belonging to genotypes GA2, NA1, and NA2, (average p-distances, 4.0%, 6.2%, and 6.1%, respectively). GA5 also displayed the largest intragenotypic range of p-distances (0%-12%). The intragenotypic p-distances for the different genotypes are shown on the diagonal of Table 2 . The average intergenotypic p-distance between the different genotypes within RSV-A ranged from 4% to 18%, including a 13.2% difference between the 2 dominant genotypes, NA1 and GA5. Among the 378 RSV-A isolates, 5 termination codons were used: 20 (5.3%) used the UAG stop codon, 298 (78.8%) used UGA, and 2 (0.5%) used UAA at position 894, whereas 55 (14.6%) used stop codon UAG at position 895, and 3 (0.79%) used UGA in position 964. For the RSV-B strains, the intragenotypic p-distances for the different genotypes detected are shown on the diagonal of Table 3 .The average intergenotypic p-distance ranged from 2% to 18%, with a 4.3% difference between the 2dominant genotypes, BA9 and BA10. Among the 224 RSV-B isolates, 2 termination codons were used: 203 (90.6%) used UAA at position 931, and 21 (9.4%) used UAG at position 952. Figure 4 indicates the amino acid alignments of the full G-proteins of genotypes identified in South Africa during 1997-2012 relative to data for the reference strains.
Analysis of Selective Pressure
Full RSV G-protein bioinformatics calculations were based on data for the complete RSV G-proteins of strains sequenced from the SARI samples and for representative full RSV Gprotein sequences for each of the genotypes previously identified in South Africa and elsewhere that were available on GenBank. The genetic changes observed because of nucleotide substitution were as follows: 196 substitutions in RSV-A strains, with 75 synonymous and 120 nonsynonymous; and 203 substitutions in RSV-B strains, with 94 synonymous and 109 nonsynonymous. The Nei-Gojobori method identified positive selection within both RSV-A and RSV-B. Genotypes SAA1, GA6, GA3, SAB1, GB4, and BA5 had Ka/Ks ratios of 1.304, 1.177, 1.051, 1.07, 1.26, and 1.42, respectively (a ratio of >1 indicates positive selection). Investigation of Ka/Ks ratios between genotypes that emerged from the GA2 genotype indicated intergenotypic positive selection between NA1, SAA2, and ON1. Intergenotypic positive selection was also identified within the BA genotype between subgenotypes BA1-BA5 and BA7 [28, 30, 31] . Calculations for positive selective sites identified 16 sites in the G-glycoprotein gene that had a posterior probability of >0.5, which indicates positive selection in both RSV-A and RSV-B [28] [29] [30] . For RSV-A, 2 positively selected sites were located in the first hypervariable region (amino acid positions 94 and 136), and 6 positively selected sites were located in the second hypervariable region (amino acid positions 233, 237, 250, 262, 274, and 290). Four amino acids ( positions 237, 262, 274, and 290) had posterior probabilities for positive selection of >90%: 1 ( position 233) had a posterior probability of >80%, 2 ( positions 136 and 250) had a posterior probability of >70%, and 1 ( position 94) had a posterior probability of >60%. For RSV-B, 1 positively selected site was located in the first hypervariable region (amino acid position 103), and 7 positively selected sites were located in the second hypervariable region (amino acid positions 209, 245, 248, 251, 268, 269, and 285). Four amino acids ( positions 251, 268, 269, and 285) were identified to be under positive selection at >90%: 1 ( position 248) had a posterior probability of >80%, 2 ( positions 103 and 209) had a posterior probability of >70%, and 1 ( position 245) had a posterior probability of >50%.
Evolutionary Rates
The evolutionary rate was estimated as 4.68 × 10 
DISCUSSION
The implementation of SARI surveillance in 4 South African provinces with distinct geographic and climatic conditions provided an opportunity to analyze the molecular epidemiology of RSV at a national level, expanding on previous work undertaken in South Africa [7, 16, 21] . Phylogenetic analysis in this study confirmed previous observations that similar genotypes dominated in Figure 2 . [7] [8] [9] [10] 12] . We also identified strains that were identical to a new genotype (ON1, identified in Canada in 2011 with a 72-bp insertion) not previously seen in South Africa, confirming the global spread of RSV strains [32] . The SARI surveillance data confirmed that although the RSV season peaked between February and May each year, ongoing low-level circulation outside of the epidemic season was detected and may contribute to the persistence of strains between seasons. Although drift within genotypes was also visible over the seasons, strains from later seasons were further from the root of each genotype across the tree. Figure 4 illustrates genotype distribution over 15 years and indicates that different genotypes cocirculate within a season, with certain genotypes dominating and then declining before being replaced with a different genotype; all genotypes originally described for both subtype A and B were replaced by 2012 [7, 10, 33] . This suggests reestablishment of annual epidemics and reinfection throughout life, indicating that vaccines targeting the G-protein would need to be evaluated for cross-protection against recent RSV strains. The GA2 genotype was first detected in 1998 and was continuously detected up to 2009 [6] . In 2007, new clusters emerged closely related to GA2 but with insignificant bootstrap values and p-distances of >4%. One of these clusters was unique to South Africa, and we named it SAA2, to follow on the previous genotype identified here in 1997, SAA1. The other clusters resembled genotypes identified in Japan before identification of NA1, the dominant genotype from 2010-2012. The ON1 genotype identified in 2011 was the first instance in which a duplication insertion was described for RSV-A [32] . It will be interesting to follow this genotype over the next seasons to see whether it will have the same impact on RSV-A evolution as the BA genotype had for RSV-B, and whether the 72-nucleotide duplication will provide an evolutionary advantage to the virus. Drift also occurred in the GA5 genotype, with p-distance analysis suggesting that 3 subclusters, GA5I-III, could be identified.
Investigation of RSV-B evolution over the 15 years showed that the BA genotype not only had replaced all the previously identified RSV-B genotypes in South Africa [6] , but is also undergoing positive selection and evolving into new genotypes. The BA genotype has become dominant since it was first described in 1999 across most of the world [6, 7, 11, 18, [34] [35] [36] . In the early investigation of the natural history of the BA genotype, it was divided into 6 subgenotypes, BA1-BA6 [20] . Further genetic drift since its emergence 13 years ago resulted in 4 new subgenotypes, BA7-BA10 [15] . The South African RSV-B strains identified since 2006 belong to 2 main genotypes, BA9 and BA10, and none of the South Africa-specific RSV-A and RSV-B genotypes identified in earlier studies (SAA1, SAA2, and SAB1-3) were identified to be circulating during 2009-2012 [6] . This may be due to community-wide immunological pressure induced by previous exposure.
We identified 7 novel positively selected sites in RSV-A (2 sites) and RSV-B (5 sites) located mainly in the second hypervariable region for the G-protein gene, confirming the value of this region in phylogenetic analysis [8, 9, 37] . This suggests that evolution of both RSV-A and RSV-B is driven by the selection of new variants because of positive selective pressure at certain codon positions. Unlike other respiratory viruses, such as influenza virus, it would be impossible to make predictions about future evolutionary changes to the G-protein, since the mechanism that drives changes in the neutralization site is not completely understood; however, immune pressure seems to be a likely explanation because positive selection has been identified, although random changes may also occur, probably because of mistakes introduced by the polymerase, and retained mutations could have an evolutionary advantage for the virus. Use of alternative stop codons and tolerance to large insertion mutations contribute to the higher evolutionary rate of RSV-B [8] [9] [10] . Emergence of a subgroup A strain with a 72-bp insertion could also provide evolutionary advantage to subgroup A.
Our study is subject to a number of limitations. We have described data from several different studies, and differences in study designs and populations (in terms of age and severity of disease) made it difficult to assess the potential association of different genotypes with disease severity among the different studies. There is also a 4-year gap (2002) (2003) (2004) (2005) in the RSV molecular data, preventing a report on the molecular changes in RSV during this period.
We have been investigating RSV genetic and antigenic variation in patients over the past 15 years. Data from these studies reflect findings from other parts of the world but also identified differences unique to our population and may provide some insight about the molecular evolution of RSV in the rest of Africa. We identified several genotypes for the first time in South Africa that have been identified across the world, suggesting that the emergence of new RSV strains in distant areas could contribute to RSV strains circulating globally and to the recurrence of annual epidemics.
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